Payment Dates and Reports. Royalty payments shall be made by Kiniksa with respect to each Product within forty-five (45) days after the end of each Calendar Quarter in which a sale of such Product is made, commencing with the Calendar Quarter in which the First Commercial Sale of such Product occurs. Kiniksa shall also provide, at the same time each such payment is made, a report showing: (a) the Net Sales of each Product by type of Product and country in the Territory; (b) the total amount of deductions from Gross Sales to determine Net Sales; (c) the applicable royalty rates for each Product on a country-by-country basis in each country in the Territory after applying any adjustments set forth in Section 5.3.2 above; (d) a calculation of the amount of royalty due to Biogen; and (e) the expected date of expiration of regulatory exclusivity of each Product in each country in the Territory where such Product is being sold.
Appears in 3 contracts
Sources: Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.), Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.), Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.)